Breaking News Instant updates and real-time market news.

GH

Guardant Health

$74.00

-3.54 (-4.57%)

16:46
04/15/19
04/15
16:46
04/15/19
16:46

NILE study recommends Guardant Health's Guardant360 assay in tissue testing

Guardant Health announced that the "positive results" from the NILE study, a head-to-head comparison of the Guardant360 assay to standard-of-care tissue testing for the identification of guideline-recommended biomarkers in first-line advanced non-small cell lung cancer patients, have been published in Clinical Cancer Research. The study adds new data regarding Guardant360's high concordance to tissue testing to the abstract that was highlighted before the AACR Annual Meeting. The study adds to a "growing body of literature" demonstrating that using Guardant360 first for genomic biomarker detection in advanced NSCLC can increase the number of patients tested for guideline-recommended biomarkers.

  • 05

    Jun

GH Guardant Health
$74.00

-3.54 (-4.57%)

03/13/19
JPMS
03/13/19
NO CHANGE
Target $85
JPMS
Overweight
Guardant Health price target raised to $85 from $42 at JPMorgan
JPMorgan analyst Tycho Peterson raised his price target for Guardant Health to $85 from $42 saying the company last night reported "strong" Q4 results, driven by solid performance in clinical testing, coupled with upside from biopharma and development services. The analyst continues to view Guardant as a "best-in-class asset in the attractive liquid biopsy space." He still sees upside from current levels and keeps an Overweight rating on the shares.
04/01/19
JPMS
04/01/19
NO CHANGE
Target $85
JPMS
Overweight
JPMorgan 'encouraged on several fronts' after Guardant Health meetings
JPMorgan analyst Tycho Peterson says he walked away from investor meetings with Guardant Health management "encouraged on several fronts." The analyst sees continued progress on reimbursement via the Palmetto draft local coverage determination and highlights management's confidence in driving volumes via ramping adoption. Guardant offers an attractive sales growth profile driven by continued traction in G360/OMNI and "steady momentum" in biopharma partnerships, as well as a "relatively clear line-of-sight" to expanded clinical reimbursement, Peterson tells investors in a research note. He continues to view Guardant Health as a "best-in-class asset in the attractive liquid biopsy space." Furthermore, the recent 20% share pullback from all-time highs heading into the lock-up expiration has resulted in renewed investor interest, says the analyst. He reiterates an Overweight rating on Guardant Health with an $85 price target.
04/03/19
COWN
04/03/19
NO CHANGE
Target $70
COWN
Outperform
Guardant Health price target raised to $70 from $40 at Cowen
Cowen analyst Doug Schenkel raised his 2019 revenue forecast for Guardant Health by about $14M to $133.8M, which he noted is consistent with management guidance and consensus. While he sees some instances where he believes some expectations for Guardant "have got a bit ahead of themselves," Schenkel keeps an Outperform rating on the shares and raised his price target to $70 from $40, citing his view that the company has established itself as "the leader in comprehensive liquid biopsy testing for metastatic cancer patients."
04/10/19
BOFA
04/10/19
UPGRADE
Target $84
BOFA
Buy
Guardant Health upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Derik de Bruin upgraded Guardant Health to Buy from Neutral and raised its price target to $84 from $81 citing growth potential despite the recent run in shares. de Bruin aid Guardant Health is a leader in liquid biopsy-based cancer testing and said expectations remain reasonable following the lock-up expiration, LUNAR-1 data release, G360 expanded coverage, and a review of the liquid-biopsy testing market.

TODAY'S FREE FLY STORIES

APHA

Aphria

$7.64

-0.17 (-2.18%)

18:23
04/25/19
04/25
18:23
04/25/19
18:23
Hot Stocks
Green Growth Brands says offer for Aphria has expired »

Green Growth Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$296.77

-0.35 (-0.12%)

18:21
04/25/19
04/25
18:21
04/25/19
18:21
Hot Stocks
Align Technology CEO: We are enjoying good growth in North America »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 15

    May

  • 05

    Jun

AAPL

Apple

$205.28

-1.82 (-0.88%)

18:21
04/25/19
04/25
18:21
04/25/19
18:21
Periodicals
Several veterans leave Apple's design team, WSJ reports »

Apple's design team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 03

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

18:18
04/25/19
04/25
18:18
04/25/19
18:18
Hot Stocks
Canadian agency says probe shows Facebook broke privacy law »

Canada's Office of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

NOV

National Oilwell

$26.44

-0.04 (-0.15%)

18:17
04/25/19
04/25
18:17
04/25/19
18:17
Earnings
National Oilwell reports Q1 EPS (20c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    May

  • 22

    May

  • 13

    Nov

FB

Facebook

$193.23

10.59 (5.80%)

18:16
04/25/19
04/25
18:16
04/25/19
18:16
Hot Stocks
Ireland's DPC opens statutory inquiry into Facebook »

Ireland's Data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

18:15
04/25/19
04/25
18:15
04/25/19
18:15
Hot Stocks
NY AG to investigate Facebook's collection of user email contact databases »

New York State Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

18:09
04/25/19
04/25
18:09
04/25/19
18:09
Hot Stocks
Amazon.com says had 'a lot of good customer wins' in Q1 »

Says: Usage growth higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

FIBK

First Interstate

$41.94

-0.63 (-1.48%)

18:08
04/25/19
04/25
18:08
04/25/19
18:08
Earnings
First Interstate reports Q1 EPS 69c, consensus 72c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

F

Ford

$9.41

-0.17 (-1.77%)

18:03
04/25/19
04/25
18:03
04/25/19
18:03
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford says improving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

PUB

People's Utah Bancorp

$28.02

0.09 (0.32%)

18:01
04/25/19
04/25
18:01
04/25/19
18:01
Earnings
People's Utah Bancorp reports Q1 EPS ,55c consensus 55c »

Reports Q1 NII $26.91M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

  • 15

    May

AEGN

Aegion

$19.44

-0.58 (-2.90%)

17:57
04/25/19
04/25
17:57
04/25/19
17:57
Hot Stocks
Aegion subsidiary awarded three contracts valued at $13M total »

Aegion announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

17:55
04/25/19
04/25
17:55
04/25/19
17:55
Hot Stocks
Amazon.com says will spend $800M in Q2 to move to one-day Prime delivery »

Says: Need to build out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

F

Ford

$9.41

-0.17 (-1.77%)

17:53
04/25/19
04/25
17:53
04/25/19
17:53
Hot Stocks
Ford CFO: Encouraged by progress made in China toward return to profitability »

Sees FY19 revenue growth,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

CIR

Circor

$34.53

-2 (-5.48%)

17:48
04/25/19
04/25
17:48
04/25/19
17:48
Earnings
Circor sees Q2 adjusted EPS 40c-48c, consensus 54c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

F

Ford

$9.41

-0.17 (-1.77%)

17:48
04/25/19
04/25
17:48
04/25/19
17:48
Hot Stocks
Ford CFO says Q1 market share declined to 5.9% from 6.5% »

Says EBIT and EBIT margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

CIR

Circor

$34.53

-2 (-5.48%)

17:46
04/25/19
04/25
17:46
04/25/19
17:46
Earnings
Circor reports Q1 adjusted EPS 38c, consensus 37c »

Reports Q1 revenue $270M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

F

Ford

$9.41

-0.17 (-1.77%)

17:45
04/25/19
04/25
17:45
04/25/19
17:45
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford sees over $1B in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

ARGO

Argo Group

$74.21

-0.245 (-0.33%)

17:43
04/25/19
04/25
17:43
04/25/19
17:43
Upgrade
Argo Group rating change at William Blair »

Argo Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 11

    Jun

ILMN

Illumina

$318.91

4.47 (1.42%)

17:36
04/25/19
04/25
17:36
04/25/19
17:36
Earnings
Illumina raises FY19 adj. EPS view to $6.63-$6.73 from $6.50-$6.60 »

Consensus $6.53. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

  • 31

    May

  • 06

    Aug

  • 03

    Sep

HTH

Hilltop Holdings

$19.90

-0.19 (-0.95%)

17:35
04/25/19
04/25
17:35
04/25/19
17:35
Earnings
Hilltop Holdings reports Q1 EPS 41c, consensus 26c »

Hilltop's annualized…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

F

Ford

$9.41

-0.17 (-1.77%)

17:35
04/25/19
04/25
17:35
04/25/19
17:35
Hot Stocks
Ford backs long-term revenue growth target view exceeding global GDP »

Backs FY19 long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

ILMN

Illumina

$318.91

4.47 (1.42%)

17:32
04/25/19
04/25
17:32
04/25/19
17:32
Earnings
Illumina reports Q1 adj. EPS $1.60, consensus $1.34 »

Reports Q1 revenue $846M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

  • 31

    May

  • 06

    Aug

  • 03

    Sep

GIB

CGI Group

$71.16

0.36 (0.51%)

17:30
04/25/19
04/25
17:30
04/25/19
17:30
Downgrade
CGI Group rating change at CIBC »

CGI Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

ARGO

Argo Group

$74.21

-0.245 (-0.33%)

17:30
04/25/19
04/25
17:30
04/25/19
17:30
Upgrade
Argo Group rating change at William Blair »

Argo Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 11

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.